Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Angelberger

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Nuclear Medicine|January 1, 1985
Dry aerosol of monodisperse millimicrospheres for ventilation imaging: production, delivery system, and clinical results in comparison with 81m-krypton and 127-xenonH Köhn, H Klech, P Angelberger, et al.
Wiener Klinische Wochenschrift|January 1, 1991
Lymphoscintigraphy using epidermal growth factor as tumour-seeking agent in uterine cervical cancerN Pateisky, C Schatten, N Vavra, et al.
Agents and Actions. Supplements|January 1, 1992
Concomitant aspirin treatment abolishes the antiatherosclerotic effects of the calcium channel blocker isradipine mediated by PGI2C Pirich, G Lupattelli, I Virgolini, et al.
Eicosanoids|January 1, 1992
Aspirin abolishes the decreased low-density lipoprotein (LDL) entry into the rabbit arterial wall induced by the calcium channel blocker isradipineH Sinzinger, I Virgolini, J O'Grady, et al.
Journal of Cardiovascular Pharmacology|April 1, 1991
Isradipine, a calcium-entry blocker, decreases vascular [125-I]low-density lipoprotein entry in hypercholesterolemic rabbitsH Sinzinger, G Lupattelli, I Virgolini, et al.
Nuclear Medicine and Biology|May 1, 1996
Combined use of 111In-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC)A Kurtaran, M Leimer, K Kaserer, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1992
Binding of 111In-labeled HDL to platelets from normolipemic volunteers and patients with heterozygous familial hypercholesterolemiaI Virgolini, S Li, Q Yang, et al.
European Journal of Nuclear Medicine|January 1, 1991
Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverageI Virgolini, F Rauscha, G Lupattelli, et al.
British Journal of Cancer|June 1, 1990
Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligandI Virgolini, C Müller, W Klepetko, et al.
British Journal of Cancer|July 14, 1998
123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancerM Raderer, A Kurtaran, M Hejna, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Nuclear Medicine|January 1, 1985
Dry aerosol of monodisperse millimicrospheres for ventilation imaging: production, delivery system, and clinical results in comparison with 81m-krypton and 127-xenonH Köhn, H Klech, P Angelberger, et al.
Wiener Klinische Wochenschrift|January 1, 1991
Lymphoscintigraphy using epidermal growth factor as tumour-seeking agent in uterine cervical cancerN Pateisky, C Schatten, N Vavra, et al.
Agents and Actions. Supplements|January 1, 1992
Concomitant aspirin treatment abolishes the antiatherosclerotic effects of the calcium channel blocker isradipine mediated by PGI2C Pirich, G Lupattelli, I Virgolini, et al.
Eicosanoids|January 1, 1992
Aspirin abolishes the decreased low-density lipoprotein (LDL) entry into the rabbit arterial wall induced by the calcium channel blocker isradipineH Sinzinger, I Virgolini, J O'Grady, et al.
Journal of Cardiovascular Pharmacology|April 1, 1991
Isradipine, a calcium-entry blocker, decreases vascular [125-I]low-density lipoprotein entry in hypercholesterolemic rabbitsH Sinzinger, G Lupattelli, I Virgolini, et al.
Nuclear Medicine and Biology|May 1, 1996
Combined use of 111In-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC)A Kurtaran, M Leimer, K Kaserer, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 1, 1992
Binding of 111In-labeled HDL to platelets from normolipemic volunteers and patients with heterozygous familial hypercholesterolemiaI Virgolini, S Li, Q Yang, et al.
European Journal of Nuclear Medicine|January 1, 1991
Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverageI Virgolini, F Rauscha, G Lupattelli, et al.
British Journal of Cancer|June 1, 1990
Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligandI Virgolini, C Müller, W Klepetko, et al.
British Journal of Cancer|July 14, 1998
123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancerM Raderer, A Kurtaran, M Hejna, et al.
Pageof 11